Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
mTOR
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
vistusertib
(AZD2014) / AstraZeneca
samotolisib
(LY3023414) / Eli Lilly
apitolisib
(GDC-0980) / Roche
bimiralisib
(PQR309) / Torqur
voxtalisib
(SAR245409) / Sanofi
niclosamide topical
(ATx 201) / UNION Therap
ABTL0812
/ Ability Pharma
AZD8055
/ AstraZeneca
ETP-47187
/ CNIO
PF-04691502
/ Pfizer
SEL-110
/ Cartesian Therap
SPN-820
/ Navitor Pharma, Supernus Pharma
WXFL10030390
/ Guangzhou JOYO Pharma
niclosamide
(DWRX2003) / Daewoong Pharma
ME-344
/ MEI
SF1126
/ SignalRx
eRapa
(encapsulated rapamycin) / Emtora Biosci
niclosamide
(FW-1022) / First Wave Bio
niclosamide novel solution
/ Bayer
BGT226
/ Novartis
DTRM-555
/ Zhejiang DTRM Biopharma
quinacrine
(CBL0102) / Incuron
sirolimus
(STN1010904) / Santen, ActualEyes
sirolimus for injection
(albumin-bound) / CSPC Pharma
salirasib
(KD 032) / Ono Pharma, Sanofi
sirolimus
(TAVT-18) / Tavanta Therap
